The Department of Health and Human Services (HHS) has signaled the long-anticipated return of the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) in its FY 2026 budget request, and this time, the program is getting a major overhaul.
As the infusion and specialty pharmacy market grows, many providers struggle with reimbursement complexities, payer scrutiny and operational inefficiencies. New research from Prochant, in partnership with the in90group, reveals that most pharmacies are unprepared to navigate these challenges, making revenue cycle management (RCM) optimization more critical than ever.
As the home medical equipment (HME) market continues to expand, providers face growing challenges in revenue collection, impacting profit margins. Increased regulation and complexity in navigating payer reimbursement requirements, particularly with Medicare Advantage and commercial payers, are driving reimbursement down, while the challenges of recruiting and retaining skilled billing and collections staff have escalated costs.